Michaela R DelPriore1, Debosmita Biswas1, Madeline C Dang1, Adrienne E Kim1, Habib Rahbar1, and Savannah C Partridge1
1Radiology, University of Washington, Seattle, WA, United States
Synopsis
On breast DWI, the relative
signal intensity of a lesion can be increased by exploiting the differences in
signal decay between tumor and normal tissue at higher b values. Computing high
b-value images rather than acquiring them directly can increase lesion
conspicuity and decrease scan times, improving the potential utility of breast
DWI for non-contrast screening. In women with invasive breast cancer, we
investigated the differences in lesion conspicuity across b-values and between
acquired and computed diffusion weighted images. Our findings showed maximal
lesion conspicuity at higher b-values (1200-1500s/mm2), with acquired
images generally providing higher conspicuity than computed images.
Introduction
Diffusion weighted imaging (DWI) has
the potential to be used as a quick, non-contrast tool for detecting and
characterizing breast cancer. In high b-value diffusion weighted images, the
differences in signal decay between cancer and normal tissues can be exploited
to increase the signal intensity of cancerous lesions relative to other tissues
and improve detectability.1 However, acquiring images at high
b-values increases image distortions due to susceptibility effects and
eddy-currents and lengthens scan times.2 By computing these high
b-value images rather than acquiring them directly, lesion conspicuity can
potentially be increased relative to lower b-value images while minimizing scan
time and maintaining image quality. The purpose of this study was to quantitatively
investigate differences in lesion conspicuity across b-values and between
acquired and computed DWI.Methods
In this IRB approved study, women
with breast cancer undergoing preoperative breast MRI were enrolled to undergo
an extra high b-value DWI scan during their exam. In addition, a diffusion
breast phantom was scanned (High Precision Devices [HPD], Boulder, CO)3.
All MRI acquisitions were performed on a 3T clinical scanner (Achieva, Philips
Healthcare, Best, Netherlands) using a 16-channel breast coil. In vivo DWI scans
were acquired with TR/TE=3500/79.9ms, NSA=2, b=0, 100, 800, 1500, 2500s/mm2,
high-b-averaging=on, scan time 3:33min. Phantom DWI scans were acquired with
TR/TE=3500/80ms, NSA=3, 26 b-values between 0-2500s/mm2, high-b-averaging=off,
scan time 13:42min. All scans were acquired with SPAIR and gradient reversal
fat suppression, FOV=360x360mm2, 30 slices, pixel size=1.8x1.8x4mm3,
in plane SENSE factor=3, and MB-SENSE factor=2.
Apparent diffusion coefficient
(ADC) maps were first generated with voxel-by-voxel fitting of:
ADC=ln(S800/S100)/(-Δb)
where S100 and S800 are
the signal intensities of the b=100s/mm2 and b=800s/mm2
images, respectively, and ∆b is the difference in b-value (700 s/mm2).
Computed high b-value images were then calculated for b-values ranging from b=200-2500s/mm2 using:
Sb=S100(e-Δb·ADC)
where
ADC is that calculated above, and ∆b is the difference in b-value between the
reference image (S100) and the computed image (Sb). Lesions were segmented on b=1500s/mm2 images and normal tissue regions were segmented
on b=0s/mm2 images using a custom threshold based semi-automated tool,4 and segmented regions were propagated to all
other b-value images. Lesion contrast-to-noise ratio (CNR) was calculated for
both computed and acquired images at each b-value:
CNR=(μlesion-μtissue)/√(σ2lesion+σ2tissue)
where μlesion and μtissue are
the mean DWI signal intensities and σlesion and σtissue are the standard deviations for the voxels
in the segmented regions. CNR
measures from computed and acquired images were compared by Wilcoxon signed-rank
test.
Results
Seventeen patients with invasive breast cancer were
evaluated (median age: 52 years), Table 1. In vivo, lesion conspicuity as measured by CNR increased with
increasing b-value, peaking at b=1500s/mm2 for acquired images and b=1200s/mm2
for computed images (Fig 1). An example case is shown (Fig 2). Computed and
acquired images exhibited similar CNR variations with b-value, although acquired
images had significantly higher CNR at b=1500s/mm2 (mean, 2.9 vs.
2.5, p=0.0013) and b=2500s/mm2 (2.4 vs. 2.0, p=0.02). Higher CNR for
acquired vs. computed images in vivo was due in part to effects of high-b-averaging
during acquisition, where more averages are performed for higher b-values to improve
SNR, as well as possible diffusion kurtosis effects presenting in tumors in high
b-value acquired images5 that could further increase CNR. Neither
high-b-averaging nor kurtosis effects are accounted for in the computed images,
which were computed from lower b images (with less averaging) using a
monoexponential signal decay model. Further post-processing of computed images by
Gaussian smoothing (standard deviation=0.8) reduced noise and improved the CNR
at high b-values to be comparable to high-b-averaged acquired images (Fig 1).
In the phantom experiment, where neither high-b-averaging
nor kurtosis were present, CNR for computed and acquired DWI were closely
matched across all b-values and increased continually up to the maximal b-value
investigated of 2500s/mm2 (Fig 3). Discussion and Conclusion
Our findings show the maximum conspicuity of invasive breast
tumors on DWI is achieved at b=1200-1500s/mm2, which is higher than
typical diagnostic breast DWI protocols. Although, optimal b-values likely vary
with breast density and other patient and tumor characteristics. Higher lesion CNR
for acquired vs. computed images at higher b-values agrees with previous
reports6, attributed to both high-b-averaging and diffusion kurtosis
effects positively influencing CNR for the directly acquired images. Post-processing
techniques such as noise filtering can overcome some of the limitations and
further enhance tumor CNR on computed images. Potential advantages of computed
DWI including shorter scan times and flexibility to retrospectively generate
images at any b-value for optimal interpretation warrant further exploration of
the value of this technique for breast imaging.
Acknowledgements
Supported
by NIH/NCI research grant R01CA207290 and in-kind support from Philips
Healthcare. References
- Woodhams,
Reiko, et al. "Diffusion-weighted Imaging of the Breast: Principles and
Clinical Applications." Radiographics 2011: 1059-1084.
- Nilsson,
M, et al. "Extrapolation-Based References Improve Motion and Eddy-Current
Correction of High B-Value DWI Data: Application in Parkinson's Disease
Dementia." PLoS One 2015: 10(11):e0141825
- High Precision Devices. "Quantitative MRI
(qMRI) Diffusion Phantom (QIBA DWI)." 2017. High Precision Devices (HPD).
-
Rahbar H, Kurland BF, Olson ML, Kitsch AE, Scheel JR, Chai X,
Usoro J, Lehman CD, Partridge SC. Diffusion Weighted Breast MRI: A
Semi-automated Voxel Selection Technique Improves Inter-Reader Reproducibility
of Apparent Diffusion Coefficient Measures. Journal of Computer
Assisted Tomography (JCAT). 2016: 40(3):428-35.
-
Iima M, Yano K, Kataoka M, et al. ”Quantitative non-Gaussian
diffusion and intravoxel incoherent motion magnetic resonance imaging:
differentiation of malignant and benign breast lesions.” Invest Radiol 2015: 50:205–211.
- Tamura, T, et al. "How to Improve the Conspicuity of Breast Tumors
on Computed High b-value Diffusion-weighted Imaging." Magn Reson Med
Sci 2018.